+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 0Days - 1Month
All Genders
ID06797219

Pilot Study of Low Level Laser Light Therapy for Treating Severe Neonatal Intraventricular Hemorrhage

Led by Rutgers, The State University of New Jersey · Updated on 2025-07-22

24

Participants Needed

2

Research Sites

56 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the feasibility of a light therapy device called EFIL for treating newborns with severe intraventricular hemorrhage IVH grades 3 and 4. This pilot study aims to assess the safety of the treatment, how well parents accept it, recruitment and consent process, retention rates, and to help design a larger future trial. The study will also track developmental milestones up to 12 months of age to better understand the interventions effects. The treatment involves using a novel laser device that emits 650nm light at an irradiance of 10 mWcm2. Newborn participants will receive the light therapy for 5 minutes twice a day over 12 days. This is an open-label study with one experimental group receiving the laser treatment. Parents will be contacted at 6 and 12 months after treatment to monitor developmental progress. During the study, researchers will conduct regular head ultrasounds weekly up to 4 months old to measure hemorrhage resorption rate, ventricle volume using anterior horn width and ventricular index, and head circumference daily up to 4 months. Neurosurgical interventions will also be tracked from birth to 4 months. The study will last through these assessments and follow-ups to gather information on safety, treatment effects, and developmental outcomes.

CONDITIONS

Brief Title

Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4

Research Team

G

Garrett Gianneschi, Medical

O

Onajovwe Fofah, Medical

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here